The global wound care management market revenue was around US$ 10.27 billion in 2022 and is estimated to reach US$ 14.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.81% during the forecast period from 2023 to 2031.
The term "wound care management" describes the thorough and methodical approach used by medical experts to diagnose, treat, and keep an eye on a variety of wounds, including burns, severe injuries, surgical incisions, and ulcers. Encouraging optimal wound healing, reducing complications, and enhancing the patient's general health are the main goals of wound care management.
Market Driving Factors
Surge in the prevalence of diseases and conditions affecting wound healing capabilities will boost the market growth. Increasing worldwide geriatric population, surge in traumatic wounds, growing number of surgeries, and the rise in the incidence of illnesses such as diabetes and obesity have all contributed to a surge in the prevalence of chronic, acute, and surgical wounds. Additionally, obesity and diabetes can dramatically rise in incidence and complexity of wounds including ulcerations, infections, and chronic wounds, all of which necessitate treatment (advanced wound management).
Rapid technological advancements boost the market. Various technological advancements in wound care have revolutionized the treatment of wounds. Cutting-edge wound dressings, such as foams, hydrocolloids, and alginate dressings, have been developed to offer optimal moisture balance, prevent infections, and encourage tissue regeneration.
The high cost of advanced wound care solutions will hamper the market growth.
Regional Analysis
Europe dominated the market and continue its dominance. This can be attributed by the European wound care management market benefits from a vigorous healthcare system and a commitment to evidence-based wound care practices. Furthermore, increasing number of surgical procedures, the prevalence of chronic conditions like ulcers and chronic wounds (including diabetic ulcers), surge in aging population, and raised surgical interventions. Therefore, these element drives the market growth.
North America is expected to dominate the market over the projection period. The growth is due to the increasing number of chronic diseases and associated ulcers and wounds. In addition, the increasing cases of chronic wounds and the necessity to correctly manage the pain and comorbidities associated with wounds and ulcers. Therefore, these factors are expected to boost the market in the region.
Segmentation Insights
Wound Type Insight
The acute wound segment is expected to dominate the market. This is due to the surge in cases of various traumatic wounds, and burns. The numerous benefits of acute wound products include decreased surgical site infections, enhanced results and patient satisfaction, and decreased hospital stays. There is also surge in the number of burn wounds across the worldwide. Since acute wound products are majorly used for treating acute wounds such as traumatic wounds.
The chronic wounds segment dominates the market. This is due to the surge in geriatric population, along with the increasing prevalence of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds which is contributed to drive segment growth.
Prominent Companies
Segmentation Outline
The global wound care management market segmentation focuses on Product, Wound Type, and Region.
By Product
By Wound Type
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL WOUND CARE MANAGEMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: WOUND CARE MANAGEMENT MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL WOUND CARE MANAGEMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL WOUND CARE MANAGEMENT MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 WOUND CARE
5.2.1 DRESSINGS
5.2.2 WOUND CARE DEVICES
5.2.3 TOPICAL AGENTS
5.2.4 OTHERS
5.3 WOUND CLOSURE
5.3.1 SUTURE
5.3.2 SURGICAL STAPLERS
5.3.3 TISSUE ADHESIVE
5.3.4 STRIPS
5.3.5 SEALANTS
5.3.6 GLUE
6 GLOBAL WOUND CARE MANAGEMENT MARKET, BY WOUND TYPE
6.1 OVERVIEW
6.2 CHRONIC WOUND
6.2.1 DIABETIC FOOT ULCER
6.2.2 PRESSURE ULCER
6.2.3 ARTERIAL AND VENOUS ULCER
6.2.4 OTHERS
6.3 ACUTE WOUND
6.3.1 SURGICAL WOUNDS
6.3.2 BURNS
6.3.3 OTHERS
7 GLOBAL WOUND CARE MANAGEMENT MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL WOUND CARE MANAGEMENT MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 3M COMPANY
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 B. BRAUN SE
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 CARDINAL HEALTH INC
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 COLOPLAST AS
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 JOHNSON & JOHNSON
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 CONVATEC GROUP PLC
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 INTEGRA LIFESCIENCES
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 MOLNLYCKE HEALTH CARE
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 MEDTRONIC PLC
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 PAUL HARTMANN AG
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.11 SMITH & NEPHEW
9.11.1 OVERVIEW
9.11.2 FINANCIAL PERFORMANCE
9.11.3 PRODUCT OUTLOOK
9.11.4 KEY DEVELOPMENTS
9.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved